Editor's Pick

Argos Therapeutics Inc (NASDAQ:ARGS) shares were up 18.12% to $6.91 in Monday's New York session and an additional 2.17% in after-hours trading to $7.06. Argos Therapeutics Inc (NASDAQ:ARGS) shares hit a high of $7.64 on Monday before sliding lower, offering an opportunity to catch a short-term pullback. Prior to the early...

Celator Pharmaceuticals Inc (NASDAQ:CPXX) shares rose 8.62% to $15.38 on Tuesday, edging close to the top of its yearly range at $17.40. Celator Pharmaceuticals Inc (NASDAQ:CPXX) could be prime for a selloff on profit-taking, as investors might be waiting to close their bullish positions on the stock around the top...

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) just picked up approval for its schizophrenia maintenance candidate. Here's all you need to know about the drug, and what it means for the company going forward. Imagine the trauma of you or a loved one losing touch with reality, feeling paranoid, experiencing auditory, visual,...

Companies discussed: GlycoMimetics Inc (NASDAQ:GLYC), Cara Therapeutics Inc (NASDAQ:CARA), Advaxis, Inc (NASDAQ:ADXS) GlycoMimetics First up, GlycoMimetics Inc (NASDAQ:GLYC). GlycoMimetics just kicked off a phase 2 trial in patient with relapsed/refractory acute myeloid leukemia. The trial is the second part of a phase 1/2 in its lead oncology candidate, GMI1271, investigating the drug in combination...

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares rose to $19.67 as of the market close on Tuesday but retreated by 0.10% to $19.65 in after hours trading. The company recently got a request from the FDA for dystrophin data before making a decision on the eteplirsen NDA. A few months back, Sarpeta Therapeutics shares...